The HIV vaccine testing in humans that uses messenger RNA technology has begun, the biotech firm Moderna and the International AIDS Vaccine Initiative said Thursday.

• NR Agarwal Industries Swings to Q2 Profit as Sales Jump 27.5%
• Petronet LNG Looks to Source US Gas Through Qatar 
• Chambal Fertilisers Climbs 5% Ahead of Q2 Results
• Minda Corp Climbs 8% on Record Q2 Revenue
• Saudi Aramco Plans to Maximise Oil Production as Exports Recover

This Phase 1 trial is being carried out in the United States among 56 healthy adults who are HIV negative.

Despite four decades of research, doctors have yet to develop a vaccine to protect people from the virus that causes AIDS, which kills hundreds of thousands of people around the world each year.

But hopes have been stirred with the success of mRNA technology, which allowed for the development of Covid-19 vaccines in record time, including one from Moderna.